ET-12 ANTI-VEGF THERAPY WITH KETOGENIC DIET AGAINST GLIOBLASTOMA IN MOUSE MODEL

NTRODUCTUION: Malignant glioma cells critically depend on glucose as the main energy source to survive and sustain their aggressive properties. The ketogenic diet (KD) has been proposed as a complementary therapy for treatment of malignant gliomas. VEGF inhibitor (bevacizumab) decreases blood supply...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neurooncol Adv
Autores principales: Sasayama, Takashi, Maeyama, Masahiro, Tanaka, Kazuhiro, Fujita, Yuichi, Hashiguchi, Mitsuru, Irino, Yasuhiro, Kohmura, Eiji
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213401/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.042
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares